90575166

Information

  • Trademark
  • 90575166
  • Serial Number
    90575166
  • Filing Date
    March 12, 2021
    3 years ago
  • Transaction Date
    June 13, 2024
    6 months ago
  • Status Date
    May 31, 2024
    7 months ago
  • Published for Opposition Date
    December 07, 2021
    3 years ago
  • Location Date
    February 01, 2022
    2 years ago
  • Status Code
    734
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    YOUNG, THOMAS PAUL
  • Attorney Docket Number
    02274-329
    Law Office Assigned Location Code
    N20
  • Owners
Mark Drawing Code
2
Case File Statements
  • GS0401: Custom manufacture of pharmaceutical, veterinary and diagnostic preparations and substances; custom manufacture of biopharmaceuticals; biomanufacturing for others, namely, processing of biopharmaceutical materials for others; consultancy services relating to manufacturing processes for pharmaceutical, veterinary and diagnostic substances; custom manufacture of recombinant proteins
  • DM0000: The mark consists of a stylized depiction of a centaur holding a caduceus symbol on its left hand.
  • GS0051: Antibacterial pharmaceuticals; diagnostic veterinary preparations; diagnostic preparations for medical purposes; diagnostic preparations, namely, antigens and antibodies for medical purposes for use in disease testing; pharmaceutical, veterinary and/or diagnostic preparations and substances produced by biochemical and/or genetic engineering methods, namely, antivirals and diagnostic preparations for veterinary and medical use; reagents for medical purposes; tests and test kits for medical and pharmaceutical purposes, namely, drug testing kits comprised of medical diagnostic reagents and assays that testing bodily fluids
  • GS0011: Chemical preparations for use in industry; chemicals used in science; reagents for scientific purposes; diagnostic preparations, namely, antigens and antibodies for scientific purposes; testing kits for scientific purposes predominantly consisting of reagents; proteins for industrial use, namely, antigens and antibodies; nucleic acids for laboratory use, namely, nucleic acid for the production of proteins produced by biochemical and/or genetic engineering methods
  • GS0421: Scientific and technological services, namely, pharmaceutical and new product research and design; scientific research and development services; research in the chemical, medical, and/or biochemical field; development of pharmaceutical, veterinary medicine and medical diagnostic substances and products and pharmaceutical research regarding methods for the manufacture thereof, namely, using biotechnological and genetically-engineered means; process development services in relation to pharmaceutical, veterinary and diagnostic substances, namely, consulting regarding the development of pharmaceutical preparations and medicines; technical consultancy in the pharmaceutical, veterinary and diagnostic sector, namely, technical consulting in the field of pharmaceutical studies; new product development services in relation to recombinant protein technology and development
Case File Event Statements
  • 10/12/2021 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/16/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/12/2021 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/15/2021 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 10/20/2021 - 3 years ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 10/20/2021 - 3 years ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 10/20/2021 - 3 years ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 10/20/2021 - 3 years ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 10/20/2021 - 3 years ago
    10 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/20/2021 - 3 years ago
    11 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/20/2021 - 3 years ago
    9 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 10/21/2021 - 3 years ago
    12 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 10/26/2021 - 3 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 11/2/2021 - 3 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/2/2021 - 3 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/2/2021 - 3 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/17/2021 - 3 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/7/2021 - 3 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/14/2022 - 2 years ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/7/2021 - 3 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/1/2022 - 2 years ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 7/16/2022 - 2 years ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/24/2023 - a year ago
    25 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/14/2022 - 2 years ago
    22 - SOU EXTENSION 1 FILED Type: EXT1
  • 7/14/2022 - 2 years ago
    23 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 1/24/2023 - a year ago
    26 - SOU EXTENSION 2 FILED Type: EXT2
  • 1/24/2023 - a year ago
    27 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 1/26/2023 - a year ago
    28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/20/2023 - a year ago
    32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/11/2024 - 11 months ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/18/2023 - a year ago
    29 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/18/2023 - a year ago
    30 - SOU EXTENSION 3 FILED Type: EXT3
  • 7/18/2023 - a year ago
    31 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 1/9/2024 - 12 months ago
    33 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 1/9/2024 - 12 months ago
    34 - SOU EXTENSION 4 FILED Type: EXT4
  • 1/9/2024 - 12 months ago
    35 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 5/31/2024 - 7 months ago
    37 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/31/2024 - 7 months ago
    38 - SOU EXTENSION 5 FILED Type: EXT5
  • 5/31/2024 - 7 months ago
    39 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 6/13/2024 - 6 months ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA